Infectious Disease Diagnostics Market Set to Reach USD 55.55 Billion by 2030, Driven by Home Testing and CRISPR Advances

Mordor Intelligence has published a new report on infectious disease diagnostics market offering a comprehensive analysis of trends, growth drivers, and future projection

Introduction

The infectious disease diagnostics market stands at USD 46.81 billion in 2025 and is on course to reach USD 55.55 billion by 2030, growing at a 3.48% CAGR. As COVID-19 testing volumes stabilize, laboratories and diagnostic firms are broadening their focus toward other critical areas including vector-borne infections, antimicrobial resistance, and novel pathogens. Rising global health risks such as dengue, mpox, and resistant bacterial strains are driving laboratories and healthcare systems to expand their testing menus. At the same time, consumer demand for at-home and over-the-counter testing is reshaping how diagnostics are accessed and delivered.

According to Mordor Intelligence, this shift is underpinned by a compound annual growth rate (CAGR) of around 3.48 percent, which reflects sustainable long-term expansion rooted in endemic disease management, climate-driven pathogen spread, and ongoing digital and molecular innovation. Key players are responding with more flexible assays, integrated software platforms, and decentralized testing strategies, laying a foundation for the next stage of growth in the infectious disease diagnostics market.

Report Overview:

https://www.mordorintelligence.com/industry-reports/infectious-disease-diagnostics-market?utm_source=openpr

Key Trends

1. Expanding Need Beyond Respiratory Testing

While respiratory infections (like influenza, RSV, and COVID) remain central, there is a growing appetite for diagnostics targeting vector-borne and emerging pathogens. Infection rates for diseases such as dengue are increasing, partly due to changing climate patterns that expand the habitats of disease-carrying vectors. This is forcing diagnostic firms to diversify their offerings, with vector-borne tests projected to grow at a healthy pace. Laboratories are also refreshing their test menus more frequently to address evolving threats, which creates recurring revenue opportunities.

2. Rise of Point-of-Care and At-Home Testing

Regulatory clearance for consumer-level tests is accelerating. Over-the-counter (OTC) diagnostics especially for sexually transmitted infections are gaining ground as regulators approve more home-based assays. This trend, when combined with telemedicine, is making testing more accessible. As a result, at-home and point-of-care formats are growing faster than traditional laboratory-based tests. Labs and manufacturers are responding by developing easy-to-use kits, remote support tools, and more automated workflows.

3. Shift Toward Software and Informatics

While assays, reagents, and kits still make up more than half of the market, software and digital tools are becoming increasingly vital. Laboratories are digitizing workflows to improve efficiency, integrate data, and deliver actionable insights. Analytics platforms, cloud reporting, and AI are enhancing result interpretation, reducing manual burden, and improving turnaround times. In many cases, companies are bundling reagents with software services, creating stickier customer relationships.

4. Emerging Technologies Challenge the Old Guard

Traditional PCR and qPCR platforms remain dominant, but CRISPR-based diagnostics are gaining traction with their potential for high sensitivity, rapid results, and simpler workflows. Isothermal amplification methods and multiplex microarrays add even more flexibility, especially for use in decentralized settings. Sequencing, including metagenomic approaches, is also being deployed more frequently, particularly in centers that handle unknown or resistant pathogens helping the infectious disease diagnostics market adapt to new challenges.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:

https://www.mordorintelligence.com/ja/industry-reports/infectious-disease-diagnostics-market?utm_source=openpr

Market Segmentation

The infectious disease diagnostics market is divided into several segments, reflecting a wide variety of applications, users, and technologies.

By Application

Hepatitis (A, B, C, D, E)

HIV / AIDS

CT/NG & Other STIs

Tuberculosis

Respiratory (Influenza, RSV, COVID-19, Others)

Vector-borne & Emerging Pathogens (Dengue, Zika, Mpox)

Hospital-Acquired Infections (MRSA, C. diff, etc.)

Others (Malaria, Lyme, Toxoplasmosis)

By Product & Service

Assays, Kits & Reagents

Instruments & Analyzers

Software & Informatics

Services & Contract Testing

By Technology

PCR & qPCR

Isothermal NAAT (LAMP, INAAT, TMA)

Immunodiagnostics (ELISA, CLIA, LFIA)

DNA/RNA Sequencing & NGS

Microarray & Multiplex Panels

CRISPR-based Diagnostics

Metagenomic & Shotgun Sequencing

By End User

Hospital & Clinical Laboratories

Reference / Central Laboratories

Point-of-Care / Decentralised Settings

Home-care & OTC Consumers

Academic & Research Institutes

By Test Setting

Laboratory-based Testing

Point-of-Care Testing

Over-the-Counter / At-Home Testing

By Sample Type

Blood / Plasma / Serum

Swab (NP/OP, Saliva)

Urine

Stool

Other Fluids (CSF, Sputum, etc.)

By Geography

North America

South America

Europe

Middle east&Africa

Asia pacific

Key Players

Major companies in the infectious disease diagnostics market are competing aggressively by combining advanced chemistry, automation, and informatics to meet evolving needs across laboratories, hospitals, and home-testing environments. Established diagnostics leaders are expanding their portfolios through significant investments in new platforms, strategic acquisitions, and technology partnerships. With strong capabilities in reagents, instruments, and digital solutions, these players are well positioned to capitalize on long-term market shifts toward at-home testing, software-driven workflows, and next-generation diagnostic technologies.

BioMérieux SA

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Becton, Dickinson and Company

Danaher

Know more about the major players in the market:

https://www.mordorintelligence.com/industry-reports/infectious-disease-diagnostics-market/companies?utm_source=openpr

Conclusion

The infectious disease diagnostics market is entering a defining era: one where demand is no longer driven solely by pandemic pressures but by a balanced, forward-looking mix of disease surveillance, consumer access, and advanced technology. With the market expected to reach US$ 55.55 billion by 2030, firms that can deliver flexible testing formats, integrate software and analytics, and innovate on sample collection and assay platforms are best poised to succeed.

As regions such as Asia-Pacific scale up diagnostics infrastructure and global health priorities shift toward endemic diseases and antimicrobial resistance, the infectious disease diagnostics market is set to maintain steady, sustainable growth. The combined rise of CRISPR-based tools, home tests, and digital labs promises a future where diagnostics are more accessible, intelligent, and responsive than ever before.



For complete market analysis, please visit the Mordor Intelligence page:

https://www.mordorintelligence.com/industry-reports/infectious-disease-diagnostics-market?utm_source=openpr

Industry related Reports:

Africa Molecular Diagnostics Market: The Africa Molecular Diagnostics Market report provides a comprehensive breakdown of the industry, segmenting it by technolog including in situ hybridization, chips and microarrays, mass spectrometry (MS), sequencing, PCR, and more along with applications such as infectious diseases, oncology, pharmacogenomics, and others. It further categorizes the market by product types, covering instruments, reagents, and additional offerings, as well as by end users, including hospitals, laboratories, and other healthcare settings. The report also analyzes the market across key geographies, such as South Africa, Nigeria, and several other African regions.

Get more insights: https://www.mordorintelligence.com/industry-reports/africa-molecular-diagnostics-market?utm_source=openpr

North American Molecular Diagnostics Market: The North American Molecular Diagnostics Market report categorizes the industry across several dimensions, including technology such as In-Situ Hybridization, Chips and Microarrays, Mass Spectrometry (MS), Sequencing, PCR, and other emerging methods along with key application areas like infectious disease, oncology, pharmacogenomics, and more. It further segments the market by product types, including instruments, reagents, and other related offerings, as well as by end users such as hospitals, laboratories, and additional healthcare settings. The report also breaks down regional performance across major countries, including the United States, Canada, and Mexico.

Get more insights: https://www.mordorintelligence.com/industry-reports/north-american-molecular-diagnostics-market-industry?utm_source=openpr

China In Vitro Diagnostics Market: The China In-Vitro Diagnostics Market report segments the industry by test type, covering clinical chemistry, molecular diagnostics, microbiology, and other categories. It further breaks down the market by product, including instruments, reagents and consumables, among others, as well as by usability, distinguishing between disposable and reusable IVD devices. The report also analyzes applications such as infectious disease, diabetes, cardiology, and more, along with key end users like hospitals and clinics. Market forecasts are presented in terms of value (USD).

Get more insights: https://www.mordorintelligence.com/industry-reports/china-in-vitro-diagnostics-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.